Drug Trial Radar · NCT02886702
A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Aug 29, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
855
Actual
Start
Sep 19, 2016
Primary completion
Aug 2, 2017
Study completion Aug 2, 2017
Sponsor
- Lead sponsor
- Fougera Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 1, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing Tazarotene Cream 0.05% to TAZORAC® (tazarotene) Cream 0.05% and Both Active Treatments to a Vehicle Control in the Treatment of Stable Plaque Psoriasis
Conditions
- Plaque Psoriasis
Interventions
Tazarotene Cream 0.05%Drug
Tazarotene Cream 0.05% to cover only the lesions with a thin film.
TAZORAC® (tazarotene) Cream 0.05%Drug
TAZORAC® (tazarotene) Cream 0.05% to cover only the lesions with a thin film.
PlaceboDrug
Placebo (vehicle of the test product) to cover only the lesions with a thin film.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment Success Assessed by IGATime frame: Week 12
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Fougera Investigational Site
Phoenix, Arizona
Fougera Investigational Site
Hot Springs, Arkansas
Fougera Investigational Site
Anaheim, California
Fougera Investigational Site
North Hollywood, California
Fougera Investigational Site
San Diego, California
Fougera Investigational Site
San Ramon, California
Fougera Investigational Site
Brandon, Florida
Fougera Investigational Site
Coral Gables, Florida
Fougera Investigational Site
Hialeah, Florida
Fougera Investigational Site
Miami, Florida
Fougera Investigational Site
Miami, Florida
Fougera Investigational Site
Miami, Florida
Fougera Investigational Site
Miami Gardens, Florida
Fougera Investigational Site
Miramar, Florida
Fougera Investigational Site
Sweetwater, Florida
Fougera Investigational Site
Tampa, Florida
Fougera Investigational Site
West Palm Beach, Florida
Fougera Investigational Site
Macon, Georgia
Fougera Investigational Site
Arlington Heights, Illinois
Fougera Investigational Site
New Albany, Indiana
Fougera Investigational Site
Plainfield, Indiana
Fougera Investigational Site
Louisville, Kentucky
Fougera Investigational Site
Lake Charles, Louisiana
Fougera Investigational Site
Saint Joseph, Missouri
Fougera Investigational Site
Henderson, Nevada
Fougera Investigational Site
High Point, North Carolina
Fougera Investigational Site
Salem, Oregon
Fougera Investigational Site
Hazleton, Pennsylvania
Fougera Investigational Site
Upper Saint Clair, Pennsylvania
Fougera Investigational Site
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.